Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-21 Option Award | 2024-02-23 4:50 pm | N/A 2034-02-21 | SAB Biotherapeutics Inc. | SABS | Bausch Christoph Lawrence CHIEF OPERATING OFFICER | 140,000 | $0 | 140,000 (Direct) | View |
| 2023-03-14 Option Award | 2023-03-16 4:28 pm | N/A 2033-03-14 | SAB Biotherapeutics Inc. | SABS | Bausch Christoph Lawrence Chief Operating Officer | 275,000 | $0 | 275,000 (Direct) | View |
| 2022-09-13 Option Award | 2022-09-15 4:45 pm | N/A 2032-09-13 | SAB Biotherapeutics Inc. | SABS | Bausch Christoph Lawrence CHIEF OPERATING OFFICER | 274,875 | $0 | 274,875 (Direct) | View |
| 2022-03-16 Option Award | 2022-03-18 9:15 pm | N/A 2032-03-16 | SAB Biotherapeutics Inc. | SABS | Bausch Christoph Lawrence Chief Science Officer | 24,972 | $0 | 24,972 (Direct) | View |
| 2021-10-22 Option Award(A) | 2021-11-24 7:37 pm | N/A 2027-03-12 | SAB Biotherapeutics Inc. | SABS | Bausch Christoph Lawrence Chief Science Officer | 294,200 | $0 | 294,200 (Direct) | View |
| 2021-10-22 Option Award | 2021-10-26 9:48 pm | N/A 2027-03-27 | SAB Biotherapeutics Inc. | SABS | Bausch Christoph Lawrence Chief Science Officer | 375,625 | $0 | 375,625 (Direct) | View |